- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Konica Minolta Launches New Handheld Ultrasound Device
Optimized for musculoskeletal assessment, needle guidance and vascular access, the PocketPro H2 wireless ultrasound unit reportedly provides 90 minutes of high-quality continuous scanning for point-of-care applications.
Combining ease of use features, strong compatibility with existing systems and robust image quality, Konica Minolta has launched the handheld, wireless ultrasound device PocketPro H2.
The ultrasound device reportedly facilitates rapid soft tissue assessment of ligaments, muscles, cartilage, inflammation, and joint instability, according to Konica Minolta. The company said clinicians can also employ the PocketPro H2 ultrasound for vascular access and needle guidance applications.
In addition to color and pulsed-wave Doppler capabilities and M-Mode functions, the PocketPro H2 offers an ergonomic design and customized imaging presets that promote ease of use.
The company noted a downloadable app allows wireless connection of the PocketPro H2 to the majority of iOS and Android smart devices and viewing of images at the point of care. Fully DICOM-compatible, the PocketPro H2 can also be linked to any PACS platform, according to Konica Minolta.
“Ultrasound has been called the new stethoscope of the 21st century and this advanced, wireless handheld unit helps clinicians do more with ultrasound at the point of care,” noted Joan Toth, a senior product marketing manager of ultrasound at Konica Minolta Healthcare.
(Editor’s note: For related content, see “Philips Set to Showcase Ultrasound Compact 5500CV at ASE Conference” and “New System Combines Diagnostic Ultrasound and Transient Elastography.”)
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
